Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Clinical trial NCT00169572 · COMPLETED

Trial details

NCT number: NCT00169572
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nausea and Vomiting Chemotherapy-Induced

Start date: 2005-02-01
Enrollment: 492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.